Learn the essential compliance steps to confidently offer biologics in Virginia. This guide covers state and FDA regulations, patient consent, and best practices to help you establish compliant stem cell therapy services.
This guide provides a structured overview for clinics and practitioners in Virginia looking to offer biologic treatments, particularly stem cell therapy. It includes federal and state regulatory guidance, patient consent requirements, and best practices to help ensure compliance.
The U.S. Food and Drug Administration (FDA) oversees the regulation of human cells, tissues, and cellular and tissue-based products (HCT/Ps), which include many biologic products. Clinics must comply with the FDA’s Investigational New Drug (IND) application process or 21 CFR Part 1271 if they intend to use biologics that do not meet minimal manipulation and homologous use standards.
In addition to FDA regulations, Virginia has state-specific requirements for administering biologics. Practitioners can refer to the Virginia Department of Health Professions for regulations regarding biologics and stem cell therapies: Virginia Department of Health Professions. The state’s guidelines are essential for ensuring compliance at the state level and cover licensing and professional standards for administering therapies.
In Virginia, only licensed medical professionals, such as physicians MDs or DOs, may administer stem cell and biologic treatments. Practitioners should meet the requirements set by the Virginia Board of Medicine, which include licensure verification, scope of practice, and continuing education. For more details, visit Virginia Board of Medicine.
Patient Informed Consent
Providers must obtain informed consent from patients before administering biologic treatments. Informed consent should include:
A clear explanation of the treatment’s experimental nature, as some biologic therapies are not FDA-approved.
Discussion of potential benefits and risks, with disclaimers that highlight the potential for unknown or limited efficacy.
A description of alternative treatment options and the voluntary nature of the treatment.
Virginia clinics should establish protocols to ensure patient safety and treatment efficacy. This includes screening procedures, risk assessment, and post-treatment follow-up requirements.
Implementing SOPs that detail every step of the patient care process, from initial assessment to post-treatment care, helps maintain high standards and ensures consistency in patient outcomes.
Clinics offering biologic therapies should carry adequate medical liability insurance, which may differ based on the specific therapies offered. Consult with a healthcare insurance provider for coverage recommendations tailored to biologics and stem cell therapy.
All marketing materials should comply with Virginia’s advertising regulations for medical practices. Avoid any claims of guaranteed success or cure for experimental treatments, and clearly disclose the investigational nature of certain therapies.
This guide is provided as an informational resource to help clinics and practitioners understand general compliance requirements for biologics in Virginia. It is not intended to serve as legal advice or replace consultation with qualified legal professionals. Regulations may vary and are subject to change; clinics and practitioners should consult legal counsel or regulatory experts for advice specific to their circumstances and ensure full compliance with all applicable federal and state laws. The authors and publishers of this guide disclaim any liability arising from its use or reliance on the information provided.
The purpose of this website is to provide information for on protocols and general information about biologics, including the regulations and basic information.
The purpose of this website is to provide information for on protocols and general information about biologics, including the regulations and basic information.
About
Our mission is to equip practitioners with essential knowledge on biologics, covering protocols, regulatory guidelines, and foundational insights. This site serves as a trusted resource for navigating the evolving landscape of stem cell applications in clinical practice.
Disclaimer
The information on this website is provided solely for informational purposes and has not been reviewed or approved by the FDA or any other regulatory authority. It does not constitute medical advice, diagnosis, treatment, or any guarantees of medical outcomes and should not be used as a substitute for formal medical education and training, nor as a substitute for consultation with qualified healthcare professionals. Similarly, the content does not provide legal advice or guidance on regulatory compliance and should not replace consultations with qualified legal professionals.
DiscoverBiologics.com makes no representations or warranties, express or implied, regarding the accuracy, reliability, or applicability of the information provided to individual health circumstances or the legal use and adoption of biological products by clinics or providers.
By accessing this website, you agree to the terms and conditions outlined herein and accept full responsibility for compliance and clinical decisions made within your practice. You also acknowledge that you have been encouraged to review the disclaimer page and understand that any reliance on the information provided is voluntary and at your own risk and sole discretion.
2025 © All Rights Reserved. DiscoverBiologics.com